The metabolic transition from anaerobic glycolysis and fatty acid β-oxidation to glycolysis coupled to oxidative phosphorylation is a key process for the transition of quiescent neural stem cells to proliferative neural progenitor cells. However, a full characterization of the metabolic shift and the involvement of mitochondria occurring during the last step of neurogenesis, from neuroblasts to neurons maturation, is still elusive. Here, we describe a model of neuroblasts, Neuro2a cells, with impaired differentiation capacity due to mitochondrial dysfunction. Using a detailed biochemical characterization consisting of steady state metabolomics and metabolic flux analysis, we found increased fatty acid β-oxidation as peculiar feature of neuroblasts with altered mitochondria. The consequent metabolic switch favored neuroblast proliferation at the expense of neuron maturation.
Introduction
Mitochondria are ubiquitous and multi-functional organelles involved in several cellular processes, such as energy production and synthesis of metabolites regulating vital functions. During the developmental process, cells change their metabolic states to support cellular differentiation [1, 2] .
Therefore, cells need a substantial amount of energy to cope with the newly established homeostasis that they have acquired during cellular differentiation. In other words, cells shift from glycolysis to oxidative phosphorylation (Oxphos), thus mitochondrial function and biogenesis are boosted during the cellular differentiation process [1, 2] . Several lines of evidences demonstrate that interference with mitochondrial biogenesis during differentiation slows down or even blocks the differentiation process [1] [2] [3] .
The neurogenic process -known as neurogenesis -in mammals is accomplished by neural stem cells (NSCs) at the prenatal phase and is maintained during postnatal stage, even though the presence of NSCs in adult brain is still matter of debate [4] [5] [6] . Mitochondria play key role in NSCs during development and adulthood to maintain proper neurological functions [7] . As mentioned above, NSCs, as well as other progenitor cells, during the generation of the neuronal lineage switch their metabolism from primarily anaerobic glycolysis and fatty acid catabolism to glycolysis that requires actively functional mitochondria [7] . In addition, glutamine metabolism is increased during of neuron differentiation [8] . Neuronal cell fate becomes more apparent at the neural progenitor cells (NPCs) stage. Neurons differentiated from NPCs undergo morphological changes via axonal and dendritic arborization, resulting in a change in cell polarity. Newborn neurons migrate to their destination and make connections with pre-existing neurons by forming synapses and integrating into an established neuronal circuit. In addition, during the transition from NSCs to NPCs, mitochondria change their shape from elongated to fragmented, a process required for cell cycle exit to support cellular differentiation [7] [8] [9] . Finally, NPCs give rise to committed neuroblasts, the last differentiation step before the mature neurons.
Several efforts have been done to disentangle the role of mitochondria and metabolism in quiescent and proliferative NSCs [10] , or during the transition from NSCs to NPCs [7, 9, 11] .
Nevertheless, little is currently known about metabolic changes and thus the role of mitochondria during the maturation phase from neuroblasts to neurons.
Here, we took advantage of a widely used model of neuroblasts, such as Neuro2a cells (N2a), with impaired differentiation capacity due to chemically induced mitochondrial dysfunction.
Biochemical characterization of these cells revealed increased fatty acid β-oxidation as peculiar feature of neuroblasts with altered mitochondria, that favored neuroblast proliferation to the detriment of neuron maturation. Our data highlighted that proper mitochondrial activity and metabolism in 8
Materials and methods

Cell lines
Neuro2a 
Cell proliferation assay
N2a cells were seeded at a density of 5 x 10 4 per cm 2 in black 96-well plates and incubated in complete medium. 24, 48 and 72 hours later, cells were washed in PBS and exposed to 32μM of Hoechst (33258, Life Technologies) in DMEM for 45 minutes at 37° C in the dark. Cells were washed again in PBS and fluorescence (wavelength of 445nm) was revealed by using EnVision plate reader (2100, Perkin Elmer).
Cell viability assay
N2a cells were seeded at a density of 5 x 10 4 per cm 2 in black 96-well plates and incubated in complete medium. 24 and 48 hours later, cells were washed in PBS and exposed to 5mg/ml of 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent in PBS for 30 minutes at 37° C. Cells were washed again in PBS, lysed in 100μl of DMSO and shacked for 5 min. Absorbance (wavelength of 590nm) was revealed by using EnVision plate reader (2100, Perkin Elmer).
ROS level quantification
N2a cells were seeded at a density of 5 x 10 4 per cm 2 in black 96-well plates and incubated in complete medium. 24 hours later, cells were washed in PBS and exposed to 10μM of H2DCFDA (D399, Life Technologies) and 32μM of Hoechst (33258, Life Technologies) in DMEM for 45 minutes at 37° C in the dark. Cells were washed again in PBS and fluorescence (wavelength of 529nm for H2DCFDA and 445nm for Hoechst, respectively) was revealed by using EnVision plate reader (2100, Perkin Elmer). 9 
Neurite quantification
N2a were fixed in formalin for 10 minutes and then stained for 20 min with the following solution:
0.02% Coomassie brilliant blue R-250 (w/v) in methanol: acetic acid: water, 46.5:7:46.5 (v/v/v) [12] .
Cells were then extensively rinsed in sterile water and images were acquired in brightfield. Cell number was quantified by ImageJ software while neurite number, neurite length and neurite contacts were quantified by NeuronJ software.
Mitochondrial DNA (mtDNA) quantity and relative transcription quantification
Total DNA and mtDNA were isolated using genomic DNA from tissues kit (Macherey-Nagel, 740952.250). Briefly, samples were scraped from dishes and spun at 2,000g for 3 min at RT. Cells were then resuspended in lysis buffer and DNA was isolated following manufacturer's instructions. 
Oxygen consumption measurements
Oxygen consumption rate (OCR) analysis on whole cells was performed by using a Clark type oxygen electrode (Hansatech, DW1 electrode chamber). N2a cells were rinsed in pre-warmed PBS (37°C) and suspended in coupled respiration buffer (2% free fatty acids-BSA, 1mM Na-pyruvate, 25 mM Dglucose, 40 ng/ml digitonin) or electron flow buffer (2% free fatty acids -BSA, 10mM Na-pyruvate, 2mM malate, 4µM carbonyl cyanide m-chlorophenyl hydrazine (CCCP), digitonin 40ng/ml).
Samples were then transferred to the electrode chamber for the oxygen consumption rate measurement. After measuring basal respiration, uncoupled and maximal respiration were evaluated by adding 5μM oligomycin and 5μM CCCP, respectively. Complex I, II and IV activities were evaluated through the electron flow protocol. Once transferred into the chamber, CI activity was evaluated. After 5µM rotenone and 2.5mM succinate addition, we assessed complex II activity. We then added 50µM antimycin A and 12.5mM/0.5mM Ascorbate/N,N,N',N'-tetramethyl-pphenylenediamine (TMPD) to measure complex IV activity. Samples values were normalized on total protein content.
Steady state metabolomics and metabolite flux analysis
Cells were grown in 6-well plates, harvested in ice-cold PBS and centrifuged at 2,000g for 3 min at 2) was used for data analysis and peak review of chromatograms. Metabolomic data were normalized by defining ! " # (relative metabolite area) as:
where xn represents the peak areas of metabolite n for samples a, b,…, z and ∑ * + ",-represents the sum of peak areas of metabolite n for samples a, b,…, z.
Relative metabolite area (! " # ) was then divided by the sum of relative metabolite areas analyzed in each sample to obtain relative metabolite abundance (m), as:
represents the sum of relative metabolite areas 1, 2, …, n for sample a. Internal standards were used to control instrument sensitivity.
For metabolic tracing analyses, N2a cells were exposed for 24 hours to [U- 13 were used to identify eventual outliers, however no outliers were detected. n (reported in each figure legends) represents number of independent cell culture preparations.
Results
Generation of a model of dysfunctional mitochondria in neuroblasts
In order to unravel the role of mitochondria and metabolism in Neuro2a (N2a) cell differentiation, we used a gene independent approach to alter mitochondrial function. Therefore, N2a cells were treated for 30 days with a low dose of ethidium bromide (EtBr, 100ng/ml). Surprisingly, undifferentiated EtBr treated N2a cells showed increased mitochondrial DNA (mtDNA) levels ( Fig.   1a ). Given the polycistronic nature of mitochondrial RNA, the analysis of a gene encoded by mitochondrial genome is indicative of mitochondrial RNA abundance. Therefore, we normalized mtND1 steady state mRNA with mtDNA levels as a proxy of mitochondrial genome transcription.
As reported in Fig. 1a , data suggest that EtBr treatment, despite increasing mtDNA content, reduced its transcription. This result was further corroborated by decreased levels of mtDNA-encoded COI (a subunit of electron transport chain (ETC) complex IV), and nuclear encoded subunit Sdhb (a subunit of ETC complex II) and Ndub8 (a subunit of ETC complex I) ( Fig. 1b ). In line with these findings, basal, uncoupled and maximal uncoupled respiration were significantly reduced in N2a EtBr-treated cells, as well as complex I, II and IV activities ( Fig. 1c and d) , while total reactive oxygen species (ROS) levels were unchanged ( Fig.1e ).
We next decided to demonstrate that chemically-induced Oxphos deficiency impacts significantly the biology of N2a cells. Based on the observation that cells exhibiting defective Oxphos are less capable to grow in galactose rich medium [14] , we evaluated cell viability in control and
EtBr-treated cells in the presence of 4.5 g/L galactose. In line with the fact that, in the absence of glucose, the ability to use galactose as energy substrate relies on Oxphos-derived ATP, EtBr-treated cells showed reduced cell growth compared to wild type ( Fig. 1f ). Notably, cell proliferation in glucose-containing media was comparable between wild type and EtBr-treated cells, suggesting that glycolysis may compensate the Oxphos deficiency ( Fig. 1g ). Collectively, these findings showed that a low dose of EtBr treatment is sufficient to alter mitochondrial function and metabolism in N2a cells.
Phenotypic effects of Oxphos deficiency on N2a differentiation
To evaluate the effects of EtBr on N2a cell differentiation, we assessed cellular morphology and the expression of differentiation markers. From a morphological point of view, N2a wild type cells properly differentiated as evidenced by neurite network formation ( Fig. 2a and Supplementary   Fig. 1a ) and cell cycle exit, sustained by reduced cell number compared to proliferating neuroblasts ( Supplementary Fig. 1b ). On the other hand, N2a EtBr-treated cells displayed reduced neurite number, length and contacts ( Fig. 2a and b ; Supplementary Fig. 1a ). Furthermore, mRNA (Tubb3) and protein levels of Tuj1 were significantly decreased in EtBr-treated cells ( Fig. 2c and d ). 13 Basal, uncoupled and maximal uncoupled respiration and ETC complex activities in wild type and EtBr differentiated cells suggested that the differentiation impairment was due to Oxphos deficiency. As shown in fig. 2e , EtBr treated N2a still retained defects in oxygen consumption rates under basal conditions and also displayed a reduction of ETC complex I activity. ETC complex II and IV activities showed a trend to increase, probably to compensate the respiratory defects in complex I. These results were further sustained by Oxphos protein levels, indeed Ndufb8 (ETC complex I subunit) was reduced while Sdhb (ETC complex II subunit) and Atp5a1 (a subunit of ATPase complex) were increased (Fig 2f and g) . Together these data demonstrated that EtBr treatment blunted N2a differentiation process as well as mitochondrial function.
Mitochondrial dysfunctional N2a neuroblasts show impaired metabolic profile
On the basis of the data previously reported and the tight relationship between mitochondria, metabolism and cell differentiation, we analyzed the intracellular metabolite levels. Supplementary Fig. 3a and b ). Overall, these data suggest that neuroblasts with dysfunctional mitochondria exhibit impaired glycolysis and amino acid metabolism. The increased levels of several carnitines strongly suggest a preferential use of fatty acids. 14 
Neuroblasts with dysfunctional mitochondria use fatty acids oxidation to sustain cell proliferation
To evaluate the dependence on extracellular lipids of both wild type and EtBr N2a cells, we used scavenger receptor, class B, type I (SR-BI) lipid transporter antagonist BLT-1 (block of lipid transport 1) and measured cell proliferation. As shown in Fig. 4a both wild type and EtBr cells showed decreased growth compared to vehicle-treated cells, suggesting that lipid uptake is requested to maintain the proliferation rate. Next, in order to discriminate if fatty acid contribution to cell proliferation is also mediated by their oxidation in mitochondria, we challenged cells with palmitate in the absence or presence of carnitine. The enzyme Ctp1a, localized on the outer mitochondrial membrane, leverages carnitine to transfer fatty acids into mitochondria, representing the rate limiting step of fatty acid oxidation. In the absence of carnitine, palmitate was uncapable to sustain cell survival ( Fig. 4b) , instead carnitine promoted fatty acid β-oxidation and sustained cell viability in EtBr-treated N2a cells (Fig. 4c) . These data were further sustained by significantly reduced cell viability in EtBr-treated cells exposed to etomoxir, the chemical inhibitor of Cpt1a (Fig. 4d ).
Furthermore, EtBr-treated N2a cultured in presence of carnitine and palmitate showed increased ROS levels (Fig. 4e ). This is probably due to the impaired Oxphos of EtBr-treated N2a that inefficiently cope with the overload of reducing cofactors (NADH and FADH2) deriving from fatty acid oxidation.
Taken together, these data demonstrated that EtBr-treated N2a cells rewired their metabolism and showed greater dependence on palmitate oxidation compared to wild type cells to sustain cell proliferation.
Neuroblasts with dysfunctional mitochondria exhibit altered tricarboxylic acid (TCA) cycle and utilization of energy substrates
To gain more detailed insight into metabolism of EtBr-treated neuroblasts, we cultured cells indicative of a single TCA cycle round was downregulated in EtBr treated cells (Fig. 5b) . On the other hand, M4 citrate (carbons 1, 2, 3 and 4), originated by the incorporation of two molecules of M2 acetyl-CoA, was increased in EtBr treated cells (Fig. 5b) . aKG (labeled in 1 and 2 deriving from citrate M2 labeled in 1 and 2) and M2 aKG (labeled carbons 3 and 6 from multiple TCA cycles) were decreased in N2a treated with EtBr ( Fig. 5c ), as well as M3 aKG produced from M4 citrate after NAD + -dependent isocitrate dehydrogenase 3 (Idh3) activity ( Fig. 5c ). Furthermore, no major differences were detected considering the incorporation of [U- 13 C6]glucose-derived carbons in oxaloacetate (OAA) (Fig. 5d) . These data indicate a major defect in Idh3 activity.
Glutamine can be utilized in the mitochondria by oxidative metabolism and/or can be routed to the cytoplasmic reductive pathway. When undifferentiated wild type and EtBr-treated N2a cells where cultured in the presence of [U-13 C5]glutamine, the levels of M2 acetyl-CoA were comparable between the two experimental conditions (Fig. 5e ). Interestingly, the M2 citrate (labeled in carbons 1 and 2) produced by the glutamine reductive pathway and Cs activity was reduced in N2a treated with EtBr ( Fig. 5f) . Similarly, M2 citrate (labeled in positions 3 and 5) derived by glutamine reductive pathway and pyruvate carboxylase activity was significantly decreased in Oxphos deficient cells (Fig.   5f ). Conversely, M5 citrate produced by reductive pathway (labeled in carbons 1, 2, 3, 5 and 6), as well as M4, M5 (labeled in positions 1, 2, 3, 4 and 5) and M6 citrate forms originated from glutamine oxidative metabolism were unchanged (Fig. 5f ). These results are further substantiated by decreased levels of M2 (derived from citrate labeled in positions 1 and 2) and M3 (produced by citrate M4) aKG detected in N2a with dysfunctional mitochondria (Fig. 5g ). Levels of M5 aKG were comparable between experimental groups, indicating that glutamine conversion to aKG is not affected by EtBr treatment (Fig 5g) . In addition, M3 OAA levels, only ascribable to reductive glutamine metabolism, were blunted in N2a cells treated with EtBr ( Fig. 5h) . Altogether, the analysis of isotopomers from glutamine labeling suggests a major defect in the reductive pathway and further confirms impaired Idh3 activity.
Next, we investigated fatty acid utilization by means of [U-13 C16]palmitate tracing. In this experimental setting, we found that the incorporation of [U-13 C16]palmitate-derived carbons in M2 acetyl-CoA was increased in EtBr-treated N2a cells compared to wild type (Fig. 5i ). Furthermore, M2 (labeled in carbons 3 and 4) and M4 citrate, as well as M2 (from citrate labeled in positions 1 and 2) and M3 aKG, generated from several rounds of the TCA cycle, were increased in N2a with dysfunctional mitochondria (Fig. 5j and 5k ). Also, M2 OAA (derived from the first TCA round) showed a trend to increase, while M3 OAA (derived from multiple TCA rounds) was decreased compared to wild type control (Fig. 5l ). These observations are consistent with the increased β- 16 oxidation as indicated by steady-state metabolomics and reduced TCA cycle flux as indicated tracing analyses.
To gain a complete overview on the fluxes of different metabolic substrates into TCA, we calculated the contribution of each labeled substrate to citrate abundance. As reported in Fig. 5m and based on the above described data, N2a EtBr-treated cells showed i) significantly less glutamine flux in the reductive pathway, ii) accumulation of glucose-derived carbons in citrate due to reduced Idh3 activity and iii) increased fatty acid oxidation. Collectively, these data demonstrated that neuroblasts with dysfunctional mitochondria shift their metabolism towards more fatty acid oxidation compared to wild type cells (Fig 5n) .
As reported above, EtBr-treated cells proliferated to the same extent of N2a wild type (Fig.   1f ). In addition, we showed that in contrast to wild type cells, N2a with defective mitochondrial function exhibited increased fatty acid oxidation and higher capacity to grow in the presence of palmitate (Fig 3 and 4) . We next sought to ascertain the fate of fatty acid-derived carbons. Indeed, several TCA cycle intermediates are substrates for amino acid synthesis, that in turn are key molecules required for cell viability. Notably, we found increased incorporation of [U- 13 C16]palmitate-derived carbons into M2 aspartate (derived from M2 OAA labeled in 1 and 2, Fig.   5l ), M2 glutamate and M2 proline (from M2 aKG labeled in 1 and 2, Fig. 5k ) in EtBr-treated N2a (Fig. 6a ). Instead, M2 glutamine (from M2 glutamate) was unchanged between groups (Fig. 6b ), while M3 glutamine (from M3 glutamate, undetectable levels) was decreased in N2a treated with EtBr compared to wild type cells (Fig. 6c ). Considering metabolic labeling with [U-13 C6]glucose, our analyses revealed unchanged levels of M2 aspartate between the experimental conditions ( Fig.6d ), while M2 glutamate, M2 proline, M2 and M3 glutamine were decreased compared to wild type control ( Fig.6e ). Furthermore, we observed decreased M2 aspartate, unchanged levels of M4 aspartate ( Fig.6f) , reduced M2 and M3 glutamate, and unchanged levels of M5 glutamate originating from [U- 13 C5]glutamine ( Fig.6g ) in EtBr-treated N2a compared to wild type cells. Moreover, we found decreased levels of M2 proline (Fig.6h ) and M5 glutamine from the same labeled substrate in N2a cells with dysfunctional mitochondria (Fig.6i ). Finally, we observed increased glucose derived M2 alanine, produced by pyruvate transamination in the cytoplasm ( Supplementary Fig.4a ), and no changes in other non-essential amino acids labeling ( Supplementary Fig. 4b, c and d) . Taken together, these data corroborate the metabolic re-channeling of glucose and palmitate derived carbons in EtBrtreated N2a cells to maintain key amino acid biosynthesis required for cell proliferation (Fig.6j ).
Discussion
Neurogenesis is a biological process beginning from neural stem cells to mature neuron formation. This process is necessary for the development of the nervous system to ensure proper cognitive functions, such as behavior, mood, memory [1, 15, 16] , and brain plasticity [17] [18] [19] [20] [21] .
During neuronal devolvement, cells experience metabolic shift from mainly anaerobic glycolysis and fatty acid oxidation to higher glucose oxidative and glutamine metabolism [1, 2] .
Neurons consumes a substantial amount of glucose and glutamine to accomplish intra and extracellular signaling, dendritic and axonal transport, to re-establish action potential, and recycling of neurotransmitters after depolarization [8] . In the last few years, also lipid metabolism has been shown to contribute to neurogenesis, indeed Knobloch and colleagues demonstrated that lipogenesis is critical for neural differentiation [22] , while fatty acid oxidation is fundamental for the proliferation of neural stem/progenitor cell pool [9, 10, 23] . However, the biochemical mechanisms leading to decreased fatty acid oxidation during neural differentiation are not yet fully understood. The main hypothesis is that fatty acids β-oxidation yields a great amount of reducing cofactors (NADH and FADH2) and acetyl-CoA, whose carbons are diverted to a limited number of anaplerotic reactions in neuron precursors. Instead, glucose and glutamine metabolism are more flexible and dynamic.
Specifically, glucose can be oxidized in the glycolysis or diverted to pentose phosphate pathway.
Then, at the end of the glycolysis, pyruvate replenishes: i) cytoplasmic lactate for NAD + recycling;
ii) TCA cycle; iii) lipid synthesis and iv) cytoplasmic alanine levels and aspartate in both mitochondria and cytosol. Glutamine is converted to glutamate by cytosolic glutaminase-catalyzed deamination. In turn, glutamate is converted to αKG in the cytoplasm by glutamic-oxaloacetic transaminase 1 (Got1) to feed glutamine reductive pathway for lipid and aspartate synthesis. Got2 catalyzes the same transamination in the mitochondria to fuel TCA cycle (oxidative pathway) [8, 24, 25] . Aspartate, glutamine and glutamate directly sustain cell proliferation, being a source of nitrogen and carbon for nucleotide biosynthesis, but also cell differentiation, being important precursors for microtubule and synapse formation, as well as neurotransmitter biosynthesis [26, 27] .
Recent findings also prove that proper cell nutrients catabolism through TCA cycle and ETC are instrumental to sustain aspartate production, and hence cell growth [28] [29] [30] [31] [32] . Nonetheless, aspartate together with acetyl-CoA forms N-acetylaspartate (NAA). NAA is fundamental for axon formation and mechanical support by functioning as acetyl groups donor to oligodendrocytes for lipid and myelin synthesis [33] . Hence, being pleiotropic metabolic alternatives, glucose and glutamine are preferred by mature neurons to support their metabolic requirements.
To sustain the metabolic rewiring during neuron maturation, mitochondria meet cellular demand by changing their dynamics and shape, thus triggering a bidirectional transcriptional program that suppresses self-renewal, promotes differentiation, and leads to greater mitochondrial functionality during neurogenesis [34] . As a proof of this notion, perturbation of mitochondrial function in quiescent radial glia-like neural stem cells due to depletion of mitochondrial transcription factor A (Tfam) reproduces multiple hallmarks of aging in hippocampal neurogenesis [35] . In addition, other evidences elucidated the metabolic changes between quiescent and proliferative NSCs [10] , or in the transition from NSCs to NPCs [7, 9, 11] . On the other hand, to date only few reports have addressed the role of mitochondria during the maturation process from neuroblasts to neurons [36] [37] [38] [39] [40] [41] , thus a detailed metabolic characterization of this transition is still incomplete.
Here, we develop a model of N2a cells with dysfunctional mitochondria to investigate the contribution of mitochondria and energy metabolism to the maturation from neuroblast to neuron.
Specifically, cells were treated with EtBr to interfere with mtDNA biology in a gene-independent fashion. Indeed, EtBr-treated N2a cells show increased mtDNA amount but reduced mtDNA transcription, leading to impaired Oxphos function and efficiency compared to wild type N2a.
Notably, EtBr-treated N2a show altered differentiation compared to wild type control due to less and shorter neurites, all of which result in a compromised cellular network formation. Conversely, the growth rate of Oxphos deficient N2a neuroblasts is unaffected, suggesting the strong ability of these cells to rewire their metabolism to sustain cell proliferation at the expense of differentiation.
Based on these findings, we focused our attention on the metabolic adaptation of EtBr-treated Altogether, our data demonstrate that during maturation from neuroblast to neuron, mitochondrial function and energy metabolism are not merely settled by nuclear transcription, instead they are interconnected and active players in the differentiation process. Moreover, we proved that 19 fatty acid β-oxidation is a biochemical brake of cell cycle exit, a key process required for neuroblasts maturation to neurons (Fig.7 ). 20 
Figure legends
